BTTC Doctors and Institutions


Committed to Discovering New Therapies

The doctors and institutions who are participating in the BTTC are compassionate experts in their respective fields and are dedicated to finding new and effective therapies for the treatment of patients with brain tumors. Feel free to contact any of these outstanding facilities to make an appointment or participate in a BTTC clinical trial.

Salt Lake City, UT

Dr. Howard Colman
Dr. Howard Colman University of Utah Huntsman Cancer Institute 801-585-0260 Director of Medical Neuro-Oncology Clinical Interests: The treatment of primary and metastatic brain tumors. The diagnosis and management of neurologic complications of cancer. His clinical research is focused on the development and testing of new therapies for brain tumors.

Bethesda, MD

Dr. Terri Armstrong
Dr. Terri Armstrong National Institutes of Health 240-760-6010 Co-Principal Investigator and Director of Patient Outcomes Research for BTTC; Senior Investigator, Patient Outcomes Program; Neuro-Oncology Branch, Center for Cancer Research, National Institutes of Health Clinical Interests: Gauging impact of treatment on symptoms, health related quality of life and neurocognitive functions in patients with primary brain tumors. Evaluation of toxicities of therapy. Symptom cluster analysis.
Dr. Mark Gilbert
Dr. Mark Gilbert National Institutes of Health 240-760-6010 Principal Investigator, Research Group for BTTC; Chief, Neuro-Oncology Branch, Center for Cancer Research, National Institutes of Health Clinical Interests: Development of new chemotherapy agents, phase I testing, pharmacology and drug resistance modulation, development of novel clinical trial strategies.
Dr. Deric Park
Dr. Deric Park National Institutes of Health 240-760-6010 Staff Clinician Neuro-Oncology Branch, Center for Cancer Research, National Institutes of Health Clinical Interests: Neuro-oncology, chordoma, meningioma, gliosarcoma and glioma predisposition syndromes.
Dr. Jing Wu
Dr. Jing Wu National Institutes of Health 240-760-6010 Staff Clinician Neuro-Oncology Branch, Center for Cancer Research, National Institutes of Health Clinical Interests: Development of pre-clinical studies and investigator-initiated clinical trials of personalized, biology-based treatments of primary CNS tumors.
Dr. Brett Theeler
Dr. Brett Theeler National Institutes of Health 240-760-6010 Clinical Collaborator, Neuro-Oncology Branch, National Institutes of Health Clinical Interests: Rare CNS neoplasms.

Houston, TX

Dr. Marta Penas-Prado
Dr. Marta Penas-Prado University of Texas MD Anderson Cancer Center 877-632-6789 Assistant Professor, Department of Neuro-Oncology Clinical Interests: Adult medulloblastoma, development of clinical trials with targeted agents for malignant gliomas, neurological complications of cancer and cancer therapies.

Kansas City, KS

Dr. Michael Salacz
Dr. Michael Salacz University of Kansas Cancer Center 913-574-1049 Assistant Professor Clinical Interests: Neuro-oncology. Developing therapies for treatment of primary and metastatic cancers of the brain and spinal cord, including cytotoxic chemotherapies, targeted therapies and immunotherapies.

Boston, MA

Dr. Patrick Wen
Dr. Patrick Wen Dana-Farber Cancer Institute 617-632-3703 Director, Center For Neuro-Oncology, Dana-Farber Cancer Institute Professor of Neurology, Harvard Medical School Clinical Interests: Focus on novel treatments of brain tumors, especially targeted molecular agents. His other clinical interests include neurologic complications of cancer.
Dr. Isabel Arrillaga
Dr. Isabel Arrillaga Massachusetts General Hospital 617-726-2862 Associate Clinical Director, Neuro-Oncology Clinical Interests: Early phase clinical trials in glioma.

Dallas, TX

Dr. Karen Fink
Dr. Karen Fink Baylor Health Care System 214-820-8690 Lead Neuro-Oncologist Clinical Interests: Bring advanced methods of treatment to her patients. It is her mission to attain the best possible outcome and an improved quality of life for all of her patients coping with a brain tumor diagnosis.
Dr. Edward Pan
Dr. Edward Pan University of Texas Southwestern Medical Center 214-645-8186 Medical Director, Annette G. Strauss Center for Neuro-Oncology Department of Neurology & Neurotherapeutics Clinical Interests: Clinical trials involving novel targeted therapies for primary malignant gliomas, low-grade gliomas, neoplastic meningitis, brain metastases, quality of life assessments and early phase translational studies.

Evanston, IL

Dr. Ryan T. Merrell
Dr. Ryan T. Merrell NorthShore University HealthSystem 847- 570-2570 Clinical Assistant Professor Clinical Interests: Primary and metastatic brain tumors, CNS lymphoma, meningiomas, novel neuroimaging techniques.

Detroit, MI

Dr. Tobias Walbert
Dr. Tobias Walbert Henry Ford Health System 313- 916-2723 Neuro-Oncologist, Hermelin Brain Tumor Center Clinical Interests: Clinical trial development, quality of life, socio-economic evaluation.

Chicago, IL

Dr. Priya Kumthekar
Dr. Priya Kumthekar Northwestern University Feinberg School of Medicine 312-695-0990 Disease Team Lead in Neuro-Oncology; Director of the Brain Metastases Program Clinical Interests: Brain cancer, brain metastases, clinical trials and quality of life.

Chapel Hill, NC

Dr. Simon Khagi
Dr. Simon Khagi University of North Carolina 984-974-8432 Director, Brain Tumor Program Clinical Interests: Novel stem cell-based therapies, neuro-immunotherapeutics, design of early phase clinical trials, and enhanced imaging techniques for brain tumors.

Cleveland, MD

Dr. David Peereboom
Dr. David Peereboom Cleveland Clinic 866-320-4573 Director, Clinical Research; Brain Tumor and Neuro-Oncology Center Clinical Interests: Benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), brain metastases, brain tumors, CNS metastatic disease, experimental therapeutics, molecular biology of brain tumors, clinical and translational trials, neuro-oncology, tumors of the brain and spine, cancer.

Winston-Salem, NC

Dr. Glenn Lesser
Dr. Glenn Lesser Wake Forest Baptist Health 336-713-5433 Louise McMichael Miracle Professor in Oncology; Associate Chief, Section on Hematology and Oncology; Wake Forest Baptist Medical Center Clinical Interests: Neuro-oncology, cancer pain control, cancer symptom management, brain tumors.

Orlando, FL

Dr. Nicholas Avgeropoulos
Dr. Nicholas Avgeropoulos Orlando Healthcare 321-843-2584 Director, Section of Neuro-Oncology Assistant Professor, University of Central Florida Clinical Interests: Expertise includes the design and conduct of clinical and translational research studies advocating the health and benefit of neuro-oncology patients.

Milwaukee, WI

Dr. George Bobustuc
Dr. George Bobustuc Aurora Advanced Healthcare 414-384-5111 Medical Director, Neuro-Oncology Clinical Interests: Working on several projects focusing on brain, breast and pancreatic cancer. He has one patent in method and composition for enhancing PGE1 production in vascular and endothelial and smooth muscle cells.

Los Angeles, CA

Dr. Jeremy Rudnick
Dr. Jeremy Rudnick Cedars-Sinai Medical Center 310-423-4818 Attending, Neuro-Oncologist Clinical Interests: Clinical trials, brain tumor vaccines, immunotherapy and molecular targeted therapy.

Columbus, OH

Dr. Vinay K. Puduvalli
Dr. Vinay K. Puduvalli Ohio State University Wexner Medical Center 614-293-4448 Professor and Director, Division of Neuro-Oncology, Arthur G. James Cancer Hospital Clinical Interests: Developing novel therapies for patients with primary brain tumors and specifically focusing on malignant gliomas. His laboratory efforts are focused on: 1) understanding the role of epigenetics in brain tumor biology and translating these findings into new treatment options; 2) identifying means to accelerate tumor cell death by activating death pathways in brain tumors.

Seattle, WA

Dr. Lynne Taylor
Dr. Lynne Taylor University of Washington Medical Center 206-598-2282 Attending Physician, University of Washington Medical Center, Seattle Cancer Care Alliance; Clinical Professor, Department of Neurology; Neuro-Oncologist, Co-Director Alvord Brain Tumor Center Clinical Interests: Clinical neuro-oncology; paraneoplastic disorders; improving conversations about goals of care; palliative care in neurology.

Austin, TX

Dr. Morris Groves
Dr. Morris Groves Texas Oncology 512-421-4105 Director of the Austin Brain Tumor Center Chair, Neuro-Oncology Research Clinical Interests: All primary and metastatic CNS tumors, leptomeningeal spread of cancer. Research interests include development of novel and targeted agents for primary and metastatic CNS cancers. Biomarkers of disease, and molecular targeted drug development, and clinical trial design.

New York, NY

Dr. Fabio Iwamoto
Dr. Fabio Iwamoto Columbia University Medical Center 212-342-0571 Assistant Professor of Neurology Deputy Director, Division of Neuro-Oncology Clinical Interests: Diagnosis, management and treatment of brain and spinal cord tumors as well as neurological complications of cancer.

Charleston, SC

Dr. David Cachia
Dr. David Cachia Medical University of South Carolina 843-792-7749 Assistant Professor, Neuro-Oncology Clinical Interests: Primary brain tumors and molecular characterization of brain tumors.